Table 2 A summary of sexually dimorphic CpG sites in the blood, placenta, or both tissues considered together. Results are presented as (A) total CpGs found, including tissue-specific and overlapping; (B) unique, tissue-specific CpGs; and (C) overlapping CpGs in each tissue. For overlapping CpGs, the loci are identical between blood and placenta tissue, but methylation levels vary
| Â | Blood | Placenta | All | |||
|---|---|---|---|---|---|---|
(A) Total CpGs | 5594 | Â | 6182 | Â | 11,543 | Â |
 Annotated to known genes | 3840 | 68.6% | 3751 | 60.7% | 7426 | 64.3% |
 Hypermeth. in males | 362 | 6.5% | 5507 | 89.1% |  |  |
(B) Tissue-specific CpGs | 5361 | 95.8% | 5949 | 96.2% | 11,310 | 98.0% |
 Annotated to known genes | 3675 | 68.6% | 3586 | 60.3% | 7261 | 64.2% |
 Hypermeth. in males | 277 | 5.2% | 5389 | 90.6% | 5666 | 50.1% |
(C) CpGs common to both tissues | 233 | 4.2% | 233 | 3.8% | 233 | 2.0% |
 Annotated to known genes | 165 | 70.8% | 165 | 70.8% | 165 | 70.8% |
 Hypermeth. in males | 85 | 36.5% | 118 | 50.6% |  |  |